Related references
Note: Only part of the references are listed.The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathway
M. Cristina Errico et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Exogenous hydrogen sulfide prevents cardiomyocyte apoptosis from cardiac hypertrophy induced by isoproterenol
Fanghao Lu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)
A-Kinase Anchoring Protein Lbc Coordinates a p38 Activating Signaling Complex Controlling Compensatory Cardiac Hypertrophy
Irene Perez Lopez et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Histopathological and immunohistochemical alterations in rat heart after thyroidectomy and the role of hemin and ketoconazole in treatment
Ehab Tousson et al.
BIOMEDICINE & PHARMACOTHERAPY (2012)
Influence of cyclovirobuxine D on intracellular [Ca2+] regulation and the expression of the calcium cycling proteins in rat myocytes
Bin Yu et al.
FITOTERAPIA (2012)
Choline inhibits angiotensin II-induced cardiac hypertrophy by intracellular calcium signal and p38 MAPK pathway
Shu Wang et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2012)
Oxidative stress and cardiac hypertrophy: a review
Subir Kumar Maulik et al.
TOXICOLOGY MECHANISMS AND METHODS (2012)
Thyroxine and cardiac electrophysiology-a forgotten physiological duo?
James Ker
THYROID RESEARCH (2012)
Interrelationship Between Cardiac Hypertrophy, Heart Failure, and Chronic Kidney Disease Endoplasmic Reticulum Stress As a Mediator of Pathogenesis
Jeffrey G. Dickhout et al.
CIRCULATION RESEARCH (2011)
Atrogin1/MAFbx What Atrophy, Hypertrophy, and Cardiac Failure Have in Common
Donghoon Lee et al.
CIRCULATION RESEARCH (2011)
Beneficial effect of Cyclovirobuxine D on heart failure rats following myocardial infarction
Bin Yu et al.
FITOTERAPIA (2011)
Blockage of Angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation
M. S. Carneiro-Ramos et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
MAPK-Activated Protein Kinase-2 in Cardiac Hypertrophy and Cyclooxygenase-2 Regulation in Heart
John M. Streicher et al.
CIRCULATION RESEARCH (2010)
Helicobacter pylori Induces ERK-dependent Formation of a Phospho-c-Fos.c-Jun Activator Protein-1 Complex That Causes Apoptosis in Macrophages
Mohammad Asim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Excessive thyroxine enhances susceptibility to apoptosis and decreases contractility of cardiomyocytes
Yun-Ying Wang et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling
Gerald W. Dorn
CARDIOVASCULAR RESEARCH (2009)
Elevated plasma free fatty acids predict sudden cardiac death:: a 6.85-year follow-up of 3315 patients after coronary angiography
Stefan Pilz et al.
EUROPEAN HEART JOURNAL (2007)
Thyroid disease and the heart
Irwin Klein et al.
CIRCULATION (2007)
Cyclovirobuxine D ameliorates acute myocardial ischemia by KATP channel opening, nitric oxide release and anti-thrombosis
Die Hu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Effects of p38 MAPK inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production
Weike Bao et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism
Chung-Wah Siu et al.
HEART (2007)
Decompensation of cardiac hypertrophy: Cellular mechanisms and novel therapeutic targets
Abhinav Diwan et al.
PHYSIOLOGY (2007)
Thyrotoxicosis and thyroid storm
Bindu Nayak et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2006)
P38 MAP kinase activity is correlated with angiotensin II type 1 receptor blocker-induced left ventricular reverse remodeling in spontaneously hypertensive heart failure rats
Qiangrong Liang et al.
JOURNAL OF CARDIAC FAILURE (2006)
Bcl-2 is a key factor for cardiac fibroblast resistance to programmed cell death
M Mayorga et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Share Paper
